15 Participants Needed

I-HoME for Caregiver Burden

VP
Overseen ByVeerawat Phongtankuel, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment I-HoME for reducing caregiver burden?

The In-Home care coordination program showed promise in reducing avoidable hospitalizations, which could indirectly lessen caregiver burden by managing health issues at home. Additionally, a mental health home visit service partnership improved caregiver satisfaction and reduced their burden, suggesting that similar home-based interventions like I-HoME might be effective.12345

Is I-HoME safe for caregivers?

Research on hospital-in-the-home care, which is similar to I-HoME, shows that there can be negative and unexpected events, but these studies help identify safety indicators to improve care. While specific safety data for I-HoME isn't available, understanding these risks can help ensure safer care environments.46789

How does the I-HoME treatment differ from other treatments for caregiver burden?

The I-HoME treatment is unique because it focuses on providing more and better information, personal counseling, and increased support during evenings, nights, and weekends, which are times when caregivers often feel the most burdened. This approach addresses the emotional and informational needs of caregivers, which are not typically the focus of other treatments.1011121314

What is the purpose of this trial?

The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.

Research Team

VP

Veerawat Phongtankuel, MD

Principal Investigator

Weill Medical College of Cornell University

Eligibility Criteria

This trial is for family caregivers of patients with advanced Alzheimer's Disease and related dementias. It aims to support them in managing end-of-life issues using a technology-based intervention called I-HoME.

Inclusion Criteria

English speaking
I care for someone over 65 with advanced dementia, rated 7a-f on the FAST scale.

Exclusion Criteria

I am between 18 and 100 years old.
Non-English speaking

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs

12 weeks
6 visits (virtual)

Follow-up

Participants are monitored for changes in caregiver anxiety, burden, perception of patient's pain, and behavioral symptoms of dementia

4 weeks

Treatment Details

Interventions

  • I-HoME
Trial Overview The study is testing the I-HoME intervention, which uses technology to help caregivers manage end-of-life care challenges for dementia patients. The focus is on assessing how feasible and acceptable this approach is for participants.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Intervention (I-HoME)Experimental Treatment1 Intervention
Participants receive video visits with a nurse practitioner for up to six visits every 2 weeks to address symptom management and care needs.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

A survey of 342 family caregivers of cancer patients in Japan revealed that caregivers of patients with moderate care needs experienced the highest time-dependent burden, indicating that the level of care required significantly impacts caregiver stress.
Younger caregivers and older patients were also found to be at greater risk for experiencing this burden, suggesting that both patient and caregiver characteristics should be considered to improve care service balance.
Care needs level in long-term care insurance system and family caregivers' self-perceived time-dependent burden in patients with home palliative care for cancer: a cross-sectional study.Otsuki, N., Yamamoto, R., Sakaguchi, Y., et al.[2022]
The In-Home pilot program, which involved 22 home care offices, enabled caregivers to report changes in care recipients' conditions after 2% of shifts, potentially helping to manage health issues at home and avoid hospitalizations.
Caregivers and care managers generally had positive attitudes towards the intervention, although challenges included staff resistance to change and the need for a flexible approach to meet diverse patient needs.
Preliminary Data on a Care Coordination Program for Home Care Recipients.Dean, KM., Hatfield, LA., Jena, AB., et al.[2018]
In a study of 68 medically complex patients with special health-care needs, caregiver burden was significantly associated with having older siblings, indicating that family dynamics can impact the stress experienced by caregivers.
For patients aged 15 years and older, caregiver burden was notably higher for those requiring home mechanical ventilation with tracheostomy, while having younger siblings appeared to reduce caregiver burden, highlighting the importance of both medical needs and family structure.
Factor-associated caregiver burden in medically complex patients with special health-care needs.Yotani, N., Ishiguro, A., Sakai, H., et al.[2016]

References

Care needs level in long-term care insurance system and family caregivers' self-perceived time-dependent burden in patients with home palliative care for cancer: a cross-sectional study. [2022]
Preliminary Data on a Care Coordination Program for Home Care Recipients. [2018]
Factor-associated caregiver burden in medically complex patients with special health-care needs. [2016]
[Profile and risk of mental illness in caregivers for home care patients]. [2020]
The influence of a mental health home visit service partnership intervention on the caregivers' home visit service satisfaction and care burden. [2018]
How safe is hospital-in-the-home care? [2020]
The incidence of adverse events among home care patients. [2022]
Prospective study of the relationship between patient falls and caregiver burden in home health care: A pilot study. [2022]
Adverse Events and Burnout: The Moderating Effects of Workgroup Identification and Safety Climate. [2021]
[Burden and possibility of respite for family caregivers]. [2019]
[Caregiver's burden of caring for patients with dementia in group living compared to to domestic and inpatient care]. [2019]
Caregiver burden among working women and homemakers taking care of psychiatric patients. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
Wives, husbands, and daughters caring for institutionalized and noninstitutionalized dementia patients: toward a model of caregiver burden. [2017]
Factors related to feelings of burden among caregivers looking after impaired elderly in Japan under the Long-Term Care insurance system. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security